Clinical Trials
13
Active:11
Completed:1
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114
Phase 2
Terminated
- Conditions
- Rheumatoid Arthritis (RA)
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2009-03-13
- Lead Sponsor
- Dainippon Sumitomo Pharma Europe LTd.
- Target Recruit Count
- 312
- Registration Number
- NCT00296257
News
No news found